Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Randomized Study of Cyclosporine and Methotrexate with or without Methylprednisolone for the Prevention of Graft-Versus-Host Disease: Improved Long-Term Survival with the Triple Prophylaxis

Tapani Ruutu, MD PhD, Anne Nihtinen, MD PhD, Riitta Niittyvuopio, MD PhD, Eeva Juvonen, MD PhD, Liisa Volin, MD PhD

Blood (2016) 128 (22): 2241.

https://doi.org/10.1182/blood.V128.22.2241.2241

Published: 2016

Journal Articles

Stem Cell Graft Cellular Composition, Hematological and Immune Recovery in NHL Patients Mobilized with or without Plerixafor: A Prospective Comparison

Jaakko Valtola, MD, Ville Varmavuo, MD PhD, Antti Ropponen, BS, Marja Pyörälä, MD PhD, Anne Nihtinen, MD PhD, Anu Kutila, MD, Kaija Vasala, MD PhD, Päivi Lehtonen, MD, Karri Penttilä, MD PhD, Taru Kuittinen, MD PhD, Tapio Nousiainen, MD PhD, Jukka Pelkonen, MD PhD, Pekka Mäntymaa, MD PhD, Esa Jantunen, MDPhD

Blood (2014) 124 (21): 1193.

https://doi.org/10.1182/blood.V124.21.1193.1193

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation for Multiple Myeloma: Possible Role in the Treatment.

Liisa Volin, MD, PhD, Heli Uotinen, MD, Riitta Niittyvuopio, MD, PhD, Eeva Juvonen, MD, PhD, Anne Nihtinen, MD, PhD, Jouni Heiskanen, MD, Vesa Lindstrom, MD, Tapani Ruutu, MD, PhD

Blood (2012) 120 (21): 3133.

https://doi.org/10.1182/blood.V120.21.3133.3133

Published: 2012

Journal Articles

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Tapani Ruutu, MD PhD, Eeva Juvonen, MD PhD, Mats Remberger, MD PhD, Kari Remes, MD PhD, Liisa Volin, Jonas Mattsson, MD PhD, Anne Nihtinen, MD, Hans Hagglund, MD PhD, Olle Ringden, MD PhD

Blood (2011) 118 (21): 488.

https://doi.org/10.1182/blood.V118.21.488.488

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation in Multiple Myeloma: One Center Experience of 86 Patients.

Liisa Volin, MD, Heli Uotinen, MD, Eeva Juvonen, MD, Anne Nihtinen, MD, Tapani Ruutu, MD

Blood (2007) 110 (11): 3033.

https://doi.org/10.1182/blood.V110.11.3033.3033

Published: 2007

NARROW

A Randomized Study of Cyclosporine and Methotrexate with or without Methylprednisolone for the Prevention of Graft-Versus-Host Disease: Improved Long-Term Survival with the Triple Prophylaxis

Stem Cell Graft Cellular Composition, Hematological and Immune Recovery in NHL Patients Mobilized with or without Plerixafor: A Prospective Comparison

Allogeneic Stem Cell Transplantation for Multiple Myeloma: Possible Role in the Treatment.

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Allogeneic Stem Cell Transplantation in Multiple Myeloma: One Center Experience of 86 Patients.

Email alerts

ASH Publications

American Society of Hematology

A Randomized Study of Cyclosporine and Methotrexate with or without Methylprednisolone for the Prevention of Graft-Versus-Host Disease: Improved Long-Term Survival with the Triple Prophylaxis

Stem Cell Graft Cellular Composition, Hematological and Immune Recovery in NHL Patients Mobilized with or without Plerixafor: A Prospective Comparison

Allogeneic Stem Cell Transplantation for Multiple Myeloma: Possible Role in the Treatment.

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Allogeneic Stem Cell Transplantation in Multiple Myeloma: One Center Experience of 86 Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only